The application of patient-derived organoid in the research of lung cancer

H. Sung, J. Ferlay, R.L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. Cancer J. Clin. 71, 209–249 (2021)

Article  Google Scholar 

R.S. Herbst, D. Morgensztern, C. Boshoff, The biology and management of non-small cell lung cancer. Nature 553, 446–454 (2018)

Article  CAS  Google Scholar 

M. Elbadawy, T. Usui, T. Mori, R. Tsunedomi, S. Hazama, R. Nabeta, T. Uchide, R. Fukushima, T. Yoshida, M. Shibutani, T. Tanaka, S. Masuda, R. Okada, R. Ichikawa, T. Omatsu, T. Mizutani, Y. Katayama, S. Noguchi, S. Iwai, T. Nakagawa, Y. Shinohara, M. Kaneda, H. Yamawaki, K. Sasaki, Establishment of a novel experimental model for muscle-invasive bladder cancer using a dog bladder cancer organoid culture. Cancer Sci. 110, 2806–2821 (2019)

Article  CAS  Google Scholar 

S.Y. Kim, S.M. Kim, S. Lim, J.Y. Lee, S.J. Choi, S.D. Yang, M.R. Yun, C.G. Kim, S.R. Gu, C. Park, A.Y. Park, S.M. Lim, S.G. Heo, H. Kim, B. C. Cho, Modeling clinical responses to targeted therapies by patient-derived organoids of advanced lung adenocarcinoma. Clin. Cancer Res. 27, 4397–4409 (2021)

Article  CAS  Google Scholar 

Z. Li, Y. Qian, W. Li, L. Liu, L. Yu, X. Liu, G. Wu, Y. Wang, W. Luo, F. Fang, Y. Liu, F. Song, Z. Cai, W. Chen, W. Huang, Human lung adenocarcinoma-derived organoid models for drug screening. iScience23, 101411 (2020)

D. Tuveson, H. Clevers, Cancer modeling meets human organoid technology. Science 364, 952–955 (2019)

Article  CAS  Google Scholar 

M. Elbadawy, Y. Sato, T. Mori, Y. Goto, K. Hayashi, M. Yamanaka, D. Azakami, T. Uchide, R. Fukushima, T. Yoshida, M. Shibutani, M. Kobayashi, Y. Shinohara, A. Abugomaa, M. Kaneda, H. Yamawaki, T. Usui, K. Sasaki, Anti-tumor effect of trametinib in bladder cancer organoid and the underlying mechanism. Cancer Biol. Ther. 22, 357–371 (2021)

Article  CAS  Google Scholar 

F. Chen, J. Liu, R.M. Flight, K.J. Naughton, A. Lukyanchuk, A.R. Edgin, X. Song, H. Zhang, K.K. Wong, H.N.B. Moseley, C. Wang, C.F. Brainson, Cellular origins of EGFR-driven lung cancer cells determine sensitivity to therapy. Adv. Sci. 8, e2101999 (2021)

Article  Google Scholar 

Y. Hu, X. Sui, F. Song, Y. Li, K. Li, Z. Chen, F. Yang, X. Chen, Y. Zhang, X. Wang, Q. Liu, C. Li, B. Zou, X. Chen, J. Wang, P. Liu, Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week. Nat. Commun. 12, 2581 (2021)

Article  CAS  Google Scholar 

N. Takahashi, H. Hoshi, A. Higa, G. Hiyama, H. Tamura, M. Ogawa, K. Takagi, K. Goda, N. Okabe, S. Muto, H. Suzuki, K. Shimomura, S. Watanabe, M. Takagi, An in vitro system for evaluating molecular targeted drugs using lung patient-derived tumor organoids. Cells 8, 481 (2019)

Article  CAS  Google Scholar 

K.K. Dijkstra, K. Monkhorst, L.J. Schipper, K.J. Hartemink, E.F. Smit, S. Kaing, R. de Groot, M.C. Wolkers, H. Clevers, E. Cuppen, E. E. Voest, Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 31, 107588 (2020)

Article  CAS  Google Scholar 

C.M. Della Corte, G. Barra, V. Ciaramella, R. Di Liello, G. Vicidomini, S. Zappavigna, A. Luce, M. Abate, A. Fiorelli, M. Caraglia, M. Santini, E. Martinelli, T. Troiani, F. Ciardiello, F. Morgillo, Antitumor activity of dual blockade of PD-L1 and MEK in NSCLC patients derived three-dimensional spheroid cultures. J. Exp. Clin. Cancer Res. 38, 253 (2019)

Article  Google Scholar 

K.K. Dijkstra, C.M. Cattaneo, F. Weeber, M. Chalabi, J. van de Haar, L.F. Fanchi, M. Slagter, D.L. van der Velden, S. Kaing, S. Kelderman, N. van Rooij, M.E. van Leerdam, A. Depla, E.F. Smit, K.J. Hartemink, R. de Groot, M.C. Wolkers, N. Sachs, P. Snaebjornsson, K. Monkhorst, J. Haanen, H. Clevers, T.N. Schumacher, E. E. Voest, Generation of tumor-reactive T cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174, 1586–1598 e1512 (2018)

C. Zheng, Y.H. Sun, X.L. Ye, H.Q. Chen, H.B. Ji, Establishment and characterization of primary lung cancer cell lines from chinese population. Acta Pharmacol. Sin 32, 385–392 (2011)

Article  Google Scholar 

A.F. Gazdar, B. Gao, J.D. Minna, Lung cancer cell lines: useless artifacts or invaluable tools for medical science? Lung Cancer 68, 309–318 (2010)

Article  Google Scholar 

D.W. Hutmacher, Biomaterials offer cancer research the third dimension. Nat. Mater. 9, 90–93 (2010)

Article  CAS  Google Scholar 

U. Ben-David, B. Siranosian, G. Ha, H. Tang, Y. Oren, K. Hinohara, C.A. Strathdee, J. Dempster, N.J. Lyons, R. Burns, A. Nag, G. Kugener, B. Cimini, P. Tsvetkov, Y.E. Maruvka, R. O’Rourke, A. Garrity, A.A. Tubelli, P. Bandopadhayay, A. Tsherniak, F. Vazquez, B. Wong, C. Birger, M. Ghandi, A.R. Thorner, J.A. Bittker, M. Meyerson, G. Getz, R. Beroukhim, T.R. Golub, Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560, 325–330 (2018)

Article  CAS  Google Scholar 

J.L. Wilding, W.F. Bodmer, Cancer cell lines for drug discovery and development. Cancer Res. 74, 2377–2384 (2014)

Article  CAS  Google Scholar 

G.J. Yoshida, Applications of patient-derived tumor xenograft models and tumor organoids. J. Hematol. Oncol. 13, 4 (2020)

Article  Google Scholar 

I.M. Meraz, M. Majidi, F. Meng, R. Shao, M.J. Ha, S. Neri, B. Fang, S.H. Lin, P.T. Tinkey, E.J. Shpall, J. Morris, J.A. Roth, An improved patient-derived xenograft humanized mouse model for evaluation of lung cancer immune responses. Cancer Immunol. Res. 7, 1267–1279 (2019)

Article  CAS  Google Scholar 

S. Abdolahi, Z. Ghazvinian, S. Muhammadnejad, M. Saleh, H. Asadzadeh Aghdaei, K. Baghaei, Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J. Transl Med. 20, 206 (2022)

Article  Google Scholar 

M.R. Junttila, F.J. de Sauvage, Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501, 346–354 (2013)

Article  CAS  Google Scholar 

R. Shi, N. Radulovich, C. Ng, N. Liu, H. Notsuda, M. Cabanero, S.N. Martins-Filho, V. Raghavan, Q. Li, A.S. Mer, J.C. Rosen, M. Li, Y.H. Wang, L. Tamblyn, N.A. Pham, B. Haibe-Kains, G. Liu, N. Moghal, M.S. Tsao, Organoid cultures as preclinical models of Non-Small Cell Lung Cancer. Clin. Cancer Res. 26, 1162–1174 (2020)

Article  Google Scholar 

A. Miura, D. Yamada, M. Nakamura, S. Tomida, D. Shimizu, Y. Jiang, T. Takao, H. Yamamoto, K. Suzawa, K. Shien, M. Yamane, M. Sakaguchi, S. Toyooka, T. Takarada, Oncogenic potential of human pluripotent stem cell-derived lung organoids with HER2 overexpression. Int. J. Cancer 149, 1593–1604 (2021)

Article  CAS  Google Scholar 

S.Y. Choi, Y.H. Cho, D.S. Kim, W. Ji, C.M. Choi, J.C. Lee, J.K. Rho, G.S. Jeong, Establishment and long-term expansion of small cell Lung Cancer patient-derived Tumor Organoids. Int. J. Mol. Sci. 22, 1349 (2021)

Article  CAS  Google Scholar 

J.H. Chen, X.P. Chu, J.T. Zhang, Q. Nie, W.F. Tang, J. Su, H.H. Yan, H.P. Zheng, Z.X. Chen, X. Chen, M.M. Song, X. Yi, P.S. Li, Y.F. Guan, G. Li, C.X. Deng, R. Rosell, Y.L. Wu, W. Z. Zhong, genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients. Thorac. Cancer 11, 2279–2290 (2020)

Article  CAS  Google Scholar 

M. Kim, H. Mun, C.O. Sung, E.J. Cho, H.J. Jeon, S.M. Chun, D.J. Jung, T.H. Shin, G.S. Jeong, D.K. Kim, E.K. Choi, S.Y. Jeong, A.M. Taylor, S. Jain, M. Meyerson, S.J. Jang, Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat. Commun. 10, 3991 (2019)

Article  Google Scholar 

P.H. Chen, L. Cai, K. Huffman, C. Yang, J. Kim, B. Faubert, L. Boroughs, B. Ko, J. Sudderth, E.A. McMillan, L. Girard, D. Chen, M. Peyton, M.D. Shields, B. Yao, D.S. Shames, H.S. Kim, B. Timmons, I. Sekine, R. Britt, S. Weber, L.A. Byers, J.V. Heymach, J. Chen, M.A. White, J.D. Minna, G. Xiao, R.J. DeBerardinis, Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells. Mol. Cell 76, 838–851 e835 (2019)

A.G. Cox, K.L. Hwang, K.K. Brown, K. Evason, S. Beltz, A. Tsomides, K. O’Connor, G.G. Galli, D. Yimlamai, S. Chhangawala, M. Yuan, E.C. Lien, J. Wucherpfennig, S. Nissim, A. Minami, D.E. Cohen, F.D. Camargo, J.M. Asara, Y. Houvras, D.Y.R. Stainier, W. Goessling, Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth. Nat. Cell. Biol. 18, 886–896 (2016)

Article  CAS  Google Scholar 

J.S. Zhao, S. Shi, H.Y. Qu, Z. Keckesova, Z.J. Cao, L.X. Yang, X. Yu, L. Feng, Z. Shi, J. Krakowiak, R.Y. Mao, Y.T. Shen, Y.M. Fan, T.M. Fu, C. Ye, D. Xu, X. Gao, J. You, W. Li, T. Liang, Z. Lu, Y.X. Feng, Glutamine synthetase licenses APC/C-mediated mitotic progression to drive cell growth. Nat. Metab. 4, 239–253 (2022)

Article  CAS  Google Scholar 

B. Chen, Y. Song, Y. Zhan, S. Zhou, J. Ke, W. Ao, Y. Zhang, Q. Liang, M. He, S. Li, F. Xie, H. Huang, W.N. Chan, A.H.K. Cheung, B.B.Y. Ma, W. Kang, K.F. To, J. Xiao, Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway. Cancer Lett. 543, 215783 (2022)

Article  CAS  Google Scholar 

B.A. Windmoller, M. Beshay, L.P. Helweg, C. Flottmann, M. Beermann, C. Forster, L. Wilkens, J.F.W. Greiner, C. Kaltschmidt, B. Kaltschmidt, Novel primary human cancer stem-like cell populations from non-small cell lung cancer: inhibition of cell survival by targeting NF-kappaB and MYC signaling. Cells 10, 1024 (2021)

Article  Google Scholar 

J.A. Taverna, C.N. Hung, D.T. DeArmond, M. Chen, C.L. Lin, P.A. Osmulski, M.E. Gaczynska, C.M. Wang, N.D. Lucio, C.W. Chou, C.L. Chen, A. Nazarullah, S.R. Lampkin, L. Qiu, D.J. Bearss, S. Warner, C.J. Whatcott, L. Mouritsen, M. Wade, S. Weitman, R.A. Mesa, N.B. Kirma, W.T. Chao, T. H. Huang, Single-cell proteomic profiling identifies combined AXL and JAK1 inhibition as a novel therapeutic strategy for lung cancer. Cancer Res. 80, 1551–1563 (2020)

Article  CAS  Google Scholar 

S.P. Rowbotham, F. Li, A.F.M. Dost, S.M. Louie, B.P. Marsh, P. Pessina, C.R. Anbarasu, C.F. Brainson, S.J. Tuminello, A. Lieberman, S. Ryeom, T.M. Schlaeger, B.J. Aronow, H. Watanabe, K.K. Wong, C.F. Kim, H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression. Nat. Commun. 9, 4559 (2018)

Article  CAS  Google Scholar 

L.J. Marshall, M. Triunfol, T. Seidle, Patient-derived xenograft vs. organoids: a preliminary analysis of cancer research output, funding and human health impact in 2014–2019. Animals 10, 1923 (2020)

Article  Google Scholar 

N. Sachs, A. Papaspyropoulos, D.D. Zomer-van Ommen, I. Heo, L. Bottinger, D. Klay, F. Weeber, G. Huelsz-Prince, N. Iakobachvili, G.D. Amatngalim, J. de Ligt, A. van Hoeck, N. Proost, M.C. Viveen, A. Lyubimova, L. Teeven, S. Derakhshan, J. Korving, H. Begthel, J.F. Dekkers, K. Kumawat, E. Ramos, M.F. van Oosterhout, G.J. Offerhaus, D.J. Wiener, E.P. Olimpio, K.K. Dijkstra, E.F. Smit, M. van der Linden, S. Jaksani, M. van de Ven, J. Jonkers, A.C. Rios, E.E. Voest, C.H. van Moorsel, C.K. van der Ent, E. Cuppen, A. van Oudenaarden, F.E. Coenjaerts, L. Meyaard, L.J. Bont, P.J. Peters, S.J. Tans, J.S. van Zon, S.F. Boj, R.G. Vries, J.M. Beekman, H. Clevers, Long-term expanding human airway organoids for disease modeling. Embo J. 38, e100300 (2019)

Article  Google Scholar 

Y. Wang, T. Jiang, Z. Qin, J. Jiang, Q. Wang, S. Yang, C. Rivard, G. Gao, T.L. Ng, M.M. Tu, H. Yu, H. Ji, C. Zhou, S. Ren, J. Zhang, P. Bunn, R.C. Doebele, D.R. Camidge, F.R. Hirsch, HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib. Ann. Oncol. 30, 447–455 (2019)

Article  CAS  Google Scholar 

Z. Zeng, J. Li, J. Zhang, Y. Li, X. Liu, J. Chen, Z. Huang, Q. Wu, Y. Gong, C. Xie, Immune and stromal scoring system associated with tumor microenvironment and prognosis: a gene-based multi-cancer analysis. J. Transl Med. 19, 330 (2021)

Article  CAS  Google Scholar 

D. Lambrechts, E. Wauters, B. Boeckx, S. Aibar, D. Nittner, O. Burton, A. Bassez, H. Decaluwe, A. Pircher, K. Van den Eynde, B. Weynand, E. Verbeken, P. De Leyn, A. Liston, J. Vansteenkiste, P. Carmeliet, S. Aerts, B. Thienpont, Phenotype molding of stromal cells in the lung tumor microenvironment. Nat. Med. 24, 1277–1289 (2018)

Article  CAS  Google Scholar 

D.F. Quail, J.A. Joyce, Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19, 1423–1437 (2013)

留言 (0)

沒有登入
gif